Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Cg Oncology Inc (NASDAQ: CGON) closed at $26.62 in the last session, up 1.22% from day before closing price of $26.30. In other words, the price has increased by $1.22 from its previous closing price. On the day, 0.93 million shares were traded. CGON stock price reached its highest trading level at $27.045 during the session, while it also had its lowest trading level at $26.32.
Ratios:
We take a closer look at CGON’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 35.32 and its Current Ratio is at 35.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $60.
On September 23, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $66.RBC Capital Mkts initiated its Outperform rating on September 23, 2024, with a $66 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when POST LEONARD E sold 1,000 shares for $28.61 per share. The transaction valued at 28,610 led to the insider holds 0 shares of the business.
POST LEONARD E sold 1,000 shares of CGON for $29,660 on Jan 13 ’25. The Director now owns 0 shares after completing the transaction at $29.66 per share. On Dec 16 ’24, another insider, Song Hong Fang, who serves as the Director of the company, sold 700,000 shares for $28.00 each. As a result, the insider received 19,600,000 and left with 3,003,931 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGON now has a Market Capitalization of 2026572544 and an Enterprise Value of 1259888000. For the stock, the TTM Price-to-Sale (P/S) ratio is 3007.66 while its Price-to-Book (P/B) ratio in mrq is 3.35. Its current Enterprise Value per Revenue stands at 1841.941 whereas that against EBITDA is -13.133.
Stock Price History:
The Beta on a monthly basis for CGON is 0.88, which has changed by -0.28440863 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, CGON has reached a high of $46.99, while it has fallen to a 52-week low of $23.91. The 50-Day Moving Average of the stock is -6.45%, while the 200-Day Moving Average is calculated to be -19.36%.
Shares Statistics:
According to the various share statistics, CGON traded on average about 712.66K shares per day over the past 3-months and 730550 shares per day over the past 10 days. A total of 67.54M shares are outstanding, with a floating share count of 46.13M. Insiders hold about 39.96% of the company’s shares, while institutions hold 66.61% stake in the company. Shares short for CGON as of 1740700800 were 6999756 with a Short Ratio of 9.82, compared to 1738281600 on 6782886. Therefore, it implies a Short% of Shares Outstanding of 6999756 and a Short% of Float of 9.2700005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
